IRON TRIANGLE PARTNERS LP
Q4 2022 Form 13-F
COS COB, CONNECTICUT
CIK 0001779763
· CRD 302077
· SEC-registered investment adviser
$557.8M Reported Value Total
IRON TRIANGLE PARTNERS LP reports 5 total accounts under management (AUM). There are 5 discretionary accounts valued at $1,141,018,483, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered
Discretionary Manager
Private funds (Form ADV)
2 funds
· $359.6M gross asset value
Hedge Fund: $359.6M
Source: Form ADV filed 2026-03-24
Reported value
$557.8M
Quarter over quarter
+13.4%
Holdings
26
Top-10 concentration
63.5%
Key People
Form ADV owners & control persons
Kevin Thomas Molloy
LIMITED PARTNER
Michael John O'Brien
CHIEF OPERATING OFFICER, CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q4 2022 13F record
Q4 2022 13F filing summary
| Period of report | December 31, 2022 |
|---|---|
| Filed | February 14, 2023 |
| Form | 13F-HR |
| Reported value | $557.8M |
| Positions | 26 |
| Change in reported value | -2.5% |
| New positions | 9 |
| Exited positions | 10 |
| Position turnover | 52.8% |
| Top-10 concentration | 63.5% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q4 2025 13F
Filed Feb 17, 2026
|
27 | $874.7M |
|
Q3 2025 13F
Filed Nov 14, 2025
|
25 | $703.3M |
|
Q2 2025 13F
Filed Aug 14, 2025
|
26 | $651.2M |
|
Q1 2025 13F
Filed May 15, 2025
|
27 | $634.4M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
22 | $908.4M |
|
Q3 2024 13F
Filed Nov 14, 2024
|
24 | $721.8M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
24 | $983.7M |
|
Q1 2024 13F
Filed May 15, 2024
|
28 | $976.3M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
26 | $772.9M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
23 | $684.2M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
22 | $748.1M |
|
Q1 2023 13F
Filed May 15, 2023
|
27 | $693.2M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
26 | $557.8M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
27 | $572.0M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
24 | $771.2M |
|
Q1 2022 13F
Filed May 16, 2022
|
28 | $840.7M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
25 | $717.7M |
|
Q3 2021 13F
Filed Nov 15, 2021
|
26 | $696.8M |
|
Q2 2021 13F
Filed Aug 16, 2021
|
26 | $970.8M |
|
Q1 2021 13F
Filed May 17, 2021
|
27 | $786.5M |
5 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q4 2022
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | ICLR ICON PLC | $43.7M | 7.84% |
| 2 | CRL CHARLES RIV LABS INTL INC | $43.6M | 7.81% |
| 3 | UHS UNIVERSAL HLTH SVCS INC | $42.3M | 7.58% |
| 4 | COO COOPER COS INC | $40.7M | 7.29% |
| 5 | SGRY SURGERY PARTNERS INC | $35.7M | 6.39% |
| 6 | GILD GILEAD SCIENCES INC | $32.1M | 5.75% |
| 7 | SNY SANOFI | $31.5M | 5.64% |
| 8 | RGEN REPLIGEN CORP | $30.1M | 5.4% |
| 9 | BSX BOSTON SCIENTIFIC CORP | $27.8M | 4.98% |
| 10 | ESTA ESTABLISHMENT LABS HLDGS INC | $26.7M | 4.79% |
| 11 | INSP INSPIRE MED SYS INC | $20.2M | 3.61% |
| 12 | UTHR UNITED THERAPEUTICS CORP DEL | $19.9M | 3.57% |
| 13 | CI CIGNA CORP NEW | $19.9M | 3.56% |
| 14 | ISRG INTUITIVE SURGICAL INC | $18.6M | 3.33% |
| 15 | ACHC ACADIA HEALTHCARE COMPANY IN | $16.5M | 2.95% |
| 16 | SRPT SAREPTA THERAPEUTICS INC | $14.0M | 2.5% |
| 17 | PACB PACIFIC BIOSCIENCES CALIF IN | $13.9M | 2.49% |
| 18 | DXCM DEXCOM INC | $13.6M | 2.44% |
| 19 | NARI INARI MED INC | $12.1M | 2.17% |
| 20 | NBIX NEUROCRINE BIOSCIENCES INC | $12.0M | 2.14% |
Values as reported on the Q4 2022 Form 13F. Every position is in the holdings table below.